Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Innothera discloses more agents for venous function deficiency

Aug. 29, 1997

SYST-EUR trial results presented

Aug. 29, 1997

DIAMOND CHF study results reported

Aug. 29, 1997

Val-HeFT will evaluate valsartan in CHF

Aug. 28, 1997

Gensia's injectable diltiazem receives ANDA approval

Aug. 28, 1997

Antiarrhythmic effects of 5-HT2 antagonist/TxA2 antagonist combination investigated

Aug. 28, 1997

Parke-Davis initiates QUASAR trial of quinapril

Aug. 28, 1997

Cardiovascular and antiarrhythmic activities of HNS-32

Aug. 27, 1997

Innothera describes agents for venous function deficiency

Aug. 27, 1997

TNF-alpha inhibitors for septic shock and other inflammatory diseases

Aug. 26, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...